Clinical profiles and treatments of all patients according to diagnosis
| Variables | STEMI | NSTEMI | UA | SCAD | P values |
| (n=211) | (n=85) | (n=68) | (n=113) | ||
| Systolic BP (mm Hg) | 127.7±25.1 | 131±33.1 | 136.1±27.0 | 127.3±20.4 | 0.089 |
| Diastolic BP (mm Hg) | 82.0±15.3 | 82.0±18.6 | 85.9±14.7 | 80.8±10.3 | 0.152 |
| Plasma glucose (mmol/L)* | 7.4 (6.2–9.9) | 7.8 (6.0–9.8) | 6.2 (5.3–8.4) | 5.9 (5.1–8.2) | < 0.001 |
| Total cholesterol (mmol/L)* | 5.0 (4.2–5.8) | 4.9 (4.2–5.5) | 4.9 (4.2–5.6) | 5.1 (3.7–5.6) | 0.633 |
| Triglycerides (mmol/L)* | 1.4 (1.0–1.8) | 1.6 (1.1–1.9) | 1.4 (1.0–2.2) | 1.5 (1.0–1.9) | 0.864 |
| HDL-chol (mmol/L) | 0.95±0.29 | 0.91±0.35 | 0.97±0.31 | 0.92±0.35 | 0.562 |
| LDL-chol (mmol/L)* | 3.4 (2.6–4.0) | 3.2 (2.6–4.1) | 3.1 (2.6–3.9) | 3.2 (2.3–3.7) | 0.157 |
| LVEF≤35% | 30 (23.8) | 12 (26.1) | 7 (18.4) | 14 (26.9) | 0.801 |
| Atrial fibrillation | 2 (0.9) | 4 (4.7) | 3 (4.4) | 3 (2.7) | 0.188 |
| LVH | 65 (30.8) | 35 (41.2) | 24 (35.3) | 21 (18.6) | 0.005 |
| Troponin T (μg/L)* | 0.86 (0.20–2.00) | 0.35 (0.15–0.78) | 0.02 (0.02–0.24) | 0.00 (0.00–0.02) | <0.001 |
| eGFR <60 mL/min | 59 (28.0) | 36 (42.4) | 13 (19.1) | 41 (36.3) | 0.008 |
| With HF or Killip class ≥2 | 80 (37.9) | 48 (56.5) | 22 (32.4) | 34 (30.1) | 0.001 |
| With concomitant stroke† | 9 (4.3) | 9 (10.6) | 0 (0.0) | 3 (2.7) | 0.008 |
| With cardiogenic shock† | 14 (6.6) | 3 (3.5) | 0 (0.0) | 0 (0.0) | 0.005 |
| Multivessel disease‡ | 63 (29.9) | 18 (21.2) | 30 (44.1) | 58 (51.3) | <0.001 |
| Onset to admission (hours) | 24.0 (7.0–48.0) | 30.0 (14.3–83.0) | 32.0 (9.0–57.0) | 36.0 (16.3–72.0) | <0.001 |
| Length of stay (days)* | 7.0 (5.0–9.0) | 6.0 (4.5–10.0) | 7.0 (5.0–10.0) | 1.0 (0.0–7.0) | <0.001 |
| Admission to intervention (hours)* | 120.0 (6.5–163.4) | 149.6 (120.0–192.0) | 144.0 (24.0–168.0) | 8.0 (4.0–149.6) | <0.001 |
| Primary PCI | 10 (4.7) | NA | NA | NA | NA |
| Thrombolysis/fibrinolysis | 13 (6.2) | NA | NA | NA | NA |
| CAG performed | 112 (53.1) | 27 (31.8) | 44 (64.7) | 90 (79.6) | <0.001 |
| Elective PCI/CABG | 30 (14.2) | 10 (11.8) | 11 (16.2) | 35 (31.0) | 0.001 |
Values are n (%) or mean±SD, unless otherwise stated. Comparison of clinical profiles was performed using one-way analysis of variance for continuous variables and Pearson’s χ2 test for categorical variables.
*Values are medians (Q1–Q3). Comparison was done using Kruskal-Wallis test.
†Comparison was performed using exact χ2 test.
‡Defined as angiographic two-vessel or three-vessel disease (stenoses ≥50% in at least two of the three major epicardial coronary arteries), which the cardiologist considered for stenting.27
BP, blood pressure; CABG, coronary artery bypass grafting; CAG, coronary angiography; eGFR, estimated glomerular filtration rate; HDL-chol, high-density lipoprotein-cholesterol; HF, heart failure; LDL-chol, low-density lipoprotein-cholesterol; LVEF, left ventricular ejection fraction; LVH, left ventricle hypertrophy; NA, not available; NSTEMI, non-ST-elevation myocardial infarction; PCI, percutaneous coronary intervention; SCAD, stable coronary artery disease; STEMI, ST-elevation myocardial infarction; UA, unstable angina.